20 June 2026
: Case report
Giant Retroperitoneal Liposarcoma Without Organ Invasion: A Rare Case Report
Rare disease
Leon B. Hajdari ABCDEF 1, Serbeze Kabashi Mucaj CEF 2,3, Bese R. Morina ACDE 1*, Egzon Daku BCF 3,4DOI: 10.12659/AJCR.952808
Am J Case Rep 2026; 27:e952808
Abstract
BACKGROUND: Retroperitoneal liposarcoma is a malignant soft tissue sarcoma arising from adipocyte precursors, with an incidence of 3-4 cases per million. Giant retroperitoneal tumors pose significant surgical challenges due to their size and proximity to vital structures.
CASE REPORT: We report the case of a 61-year-old woman who presented with progressive abdominal distension, mild discomfort, nausea, dyspepsia, and exertional dyspnea. Preoperative MRI revealed a giant retroperitoneal mass (28×23.6×24 cm) with heterogeneous adipose and non-lipomatous components, initially suggestive of dedifferentiated liposarcoma. However, ultrasound-guided core needle biopsy revealed histopathological findings consistent with well-differentiated liposarcoma (WDLPS). Complete surgical excision via midline laparotomy was performed; the tumor weighed 10 kg. Despite the massive tumor size, complete tumor removal was achieved while preserving adjacent organs, without the need for multivisceral resection. Histopathological examination was consistent with WDLPS with negative margins (R0), no vascular invasion (V0); staged pT4. Postoperative MRI, whole-body scintigraphy, and PET/CT showed no residual or metastatic disease. No adjuvant therapy was administered, and at 3-month short-term follow-up, there was no evidence of residual or recurrent disease.
CONCLUSIONS: This case suggests the feasibility of complete surgical excision with organ preservation in selected cases of giant retroperitoneal liposarcoma with clear dissection planes. It also underscores the role of preoperative imaging and core needle biopsy in diagnostic evaluation and surgical planning. Surgery remains the standard treatment, while the role of adjuvant therapy depends on histological subtype. Longer follow-up is required to assess long-term oncologic outcomes.
Keywords: Biopsy, Needle, Case Reports, Liposarcoma, Magnetic Resonance Imaging, Retroperitoneal Neoplasms, surgical oncology
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






